A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery - Related Studies

A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

This study has been completed.

Study NCT00032084. Last updated on November 26, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Non-Small-Cell Lung
		Lung Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		bupropion hydrochloride
		nicotine
		psychosocial assessment and care
		smoking cessation intervention

5	Additional drug interventions recognized in this trial
		Bupropion

6	More general drug interventions related to this trial
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Central Nervous System Agents
		Dopamine Agents
		Dopamine Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Southwest Oncology Group
		National Cancer Institute (NCI)
		Cancer and Leukemia Group B
		Eastern Cooperative Oncology Group